These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30337545)

  • 1. Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice.
    Hu Y; Peng J; Li F; Wong FS; Wen L
    Sci Rep; 2018 Oct; 8(1):15451. PubMed ID: 30337545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral insulin does not alter gut microbiota composition of NOD mice.
    Kihl P; Krych L; Buschard K; Wesley JD; Kot W; Hansen AK; Nielsen DS; von Herrath MG
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3010. PubMed ID: 29637693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.
    Krych Ł; Nielsen DS; Hansen AK; Hansen CH
    Gut Microbes; 2015; 6(2):101-9. PubMed ID: 25648687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.
    Mullaney JA; Stephens JE; Geeling BE; Hamilton-Williams EE
    Immunol Cell Biol; 2019 Jan; 97(1):97-103. PubMed ID: 30191611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice.
    Simon MC; Reinbeck AL; Wessel C; Heindirk J; Jelenik T; Kaul K; Arreguin-Cano J; Strom A; Blaut M; Bäckhed F; Burkart V; Roden M
    J Biol Chem; 2020 Jan; 295(4):969-980. PubMed ID: 31822562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice.
    Greiner TU; Hyötyläinen T; Knip M; Bäckhed F; Orešič M
    PLoS One; 2014; 9(11):e110359. PubMed ID: 25390735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.
    Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L
    Front Immunol; 2019; 10():2654. PubMed ID: 31798584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor.
    Neuman V; Cinek O; Funda DP; Hudcovic T; Golias J; Kramna L; Petruzelkova L; Pruhova S; Sumnik Z
    Diabetologia; 2019 Jul; 62(7):1291-1296. PubMed ID: 31025045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term effect of gut microbiota transfer on diabetes development.
    Peng J; Narasimhan S; Marchesi JR; Benson A; Wong FS; Wen L
    J Autoimmun; 2014 Sep; 53():85-94. PubMed ID: 24767831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus.
    Lv W; Graves DT; He L; Shi Y; Deng X; Zhao Y; Dong X; Ren Y; Liu X; Xiao E; Zhang Y
    Theranostics; 2020; 10(14):6500-6516. PubMed ID: 32483466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
    Candon S; Perez-Arroyo A; Marquet C; Valette F; Foray AP; Pelletier B; Milani C; Ventura M; Bach JF; Chatenoud L
    PLoS One; 2015; 10(5):e0125448. PubMed ID: 25970503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.
    Livanos AE; Greiner TU; Vangay P; Pathmasiri W; Stewart D; McRitchie S; Li H; Chung J; Sohn J; Kim S; Gao Z; Barber C; Kim J; Ng S; Rogers AB; Sumner S; Zhang XS; Cadwell K; Knights D; Alekseyenko A; Bäckhed F; Blaser MJ
    Nat Microbiol; 2016 Aug; 1(11):16140. PubMed ID: 27782139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice.
    Fahey JR; Lyons BL; Olekszak HL; Mourino AJ; Ratiu JJ; Racine JJ; Chapman HD; Serreze DV; Baker DL; Hendrix NK
    Comp Med; 2017 Aug; 67(4):335-343. PubMed ID: 28830580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiome in the NOD Mouse.
    Peng J; Hu Y; Wong FS; Wen L
    Methods Mol Biol; 2016; 1433():169-77. PubMed ID: 27032947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.
    Wolf KJ; Daft JG; Tanner SM; Hartmann R; Khafipour E; Lorenz RG
    J Histochem Cytochem; 2014 Apr; 62(4):237-50. PubMed ID: 24453191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes.
    Gudi R; Perez N; Johnson BM; Sofi MH; Brown R; Quan S; Karumuthil-Melethil S; Vasu C
    Immunology; 2019 May; 157(1):70-85. PubMed ID: 30712258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Human Derived Upper gut Commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice.
    Marietta E; Horwath I; Meyer S; Khaleghi-Rostamkolaei S; Norman E; Luckey D; Balakrishnan B; Mangalam A; Choung RS; Taneja V; Murray JA
    BMC Microbiol; 2022 Jan; 22(1):8. PubMed ID: 34983374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.